What's breaking now, across thousands of outlets.
Plus news about Boehringer, Envisagenics, Ionis, Otsuka, Merck, Lexeo and Mantle. Amgen gets a win from Horizon buyout: Amgen said dazodalibep, a CD40 ligand antagonist, succeeded in a Phase ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
[New Era] Namibia is currently grappling with an acute shortage of 330 regional social workers, including community liaison officers, administrative officers and support staff, to help deliver…
Biopharmaceutical firm Specialised Therapeutics extended its commercial agreement with Incyte Biosciences to handle regulatory registration distribution and commercialisation of ruxolitinib cream in…
Following transcatheter aortic valve implantation (TAVI), disturbances in the heart's electrical conduction system can make a pacemaker necessary.
The Drugs Controller General of India advises that all non-steroidal anti-inflammatory drugs (NSAIDs) and antibiotics must be sold and distributed only on the prescription of a registered medical…
Celldex said its experimental treatment barzolvolimab hit its primary endpoint in two Phase 3 trials, even as the readout raised safety concerns on two life-threatening cases of allergic reaction…
Long-term research finds most children recovered from the effects of the pandemic.
